FDA advisory panel votes 19-0 to endorse booster dose of J&J vaccine
For an archived version of live coverage of the hearing of the FDA’s advisory panel, click here.
A Food and Drug Administration advisory panel voted Friday that booster shots should be made available to people who have received the Johnson & Johnson Covid-19 vaccine.
Read Original Article: FDA advisory panel votes 19-0 to endorse booster dose of J&J vaccine »